Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 9/15/10 → 3/31/18 |
Funding
- Takeda Pharmaceuticals North America Inc: $37,744.00
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects with Gout and Cardiovascular Comorbidities
- Lohr, Kristine (PI)